NasdaqGS:TXGLife Sciences
Could 10x Genomics' (TXG) PERIBLOOD Collaboration Reveal Shifts in Clinical Adoption Strategies?
CLISEQ Ltd. recently announced a multi-year international research collaboration with 10x Genomics and the Weizmann Institute to launch the PERIBLOOD clinical trial, aiming to evaluate peripheral single cell RNA sequencing as a less invasive alternative to bone marrow aspiration for diagnosing hematologic disorders.
This marks one of the first large-scale clinical studies applying single cell transcriptomics in real-world settings, potentially shaping future standards for non-invasive...